1. Home
  2. POAI vs AMBO Comparison

POAI vs AMBO Comparison

Compare POAI & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • AMBO
  • Stock Information
  • Founded
  • POAI 2002
  • AMBO 2000
  • Country
  • POAI United States
  • AMBO United States
  • Employees
  • POAI N/A
  • AMBO N/A
  • Industry
  • POAI Industrial Specialties
  • AMBO Other Consumer Services
  • Sector
  • POAI Health Care
  • AMBO Real Estate
  • Exchange
  • POAI Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • POAI 8.9M
  • AMBO 8.8M
  • IPO Year
  • POAI N/A
  • AMBO 2010
  • Fundamental
  • Price
  • POAI $0.86
  • AMBO $2.46
  • Analyst Decision
  • POAI Hold
  • AMBO
  • Analyst Count
  • POAI 1
  • AMBO 0
  • Target Price
  • POAI N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • POAI 103.1K
  • AMBO 5.8K
  • Earning Date
  • POAI 08-12-2025
  • AMBO 01-01-0001
  • Dividend Yield
  • POAI N/A
  • AMBO N/A
  • EPS Growth
  • POAI N/A
  • AMBO N/A
  • EPS
  • POAI N/A
  • AMBO 0.11
  • Revenue
  • POAI $1,729,269.00
  • AMBO $9,392,000.00
  • Revenue This Year
  • POAI $486.27
  • AMBO N/A
  • Revenue Next Year
  • POAI $65.50
  • AMBO N/A
  • P/E Ratio
  • POAI N/A
  • AMBO $22.82
  • Revenue Growth
  • POAI 24.17
  • AMBO 2.50
  • 52 Week Low
  • POAI $0.55
  • AMBO $1.00
  • 52 Week High
  • POAI $3.06
  • AMBO $5.55
  • Technical
  • Relative Strength Index (RSI)
  • POAI 39.19
  • AMBO 44.99
  • Support Level
  • POAI $0.82
  • AMBO $2.34
  • Resistance Level
  • POAI $0.87
  • AMBO $2.70
  • Average True Range (ATR)
  • POAI 0.05
  • AMBO 0.16
  • MACD
  • POAI -0.00
  • AMBO 0.01
  • Stochastic Oscillator
  • POAI 21.68
  • AMBO 47.79

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: